Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age Macular Degeneration”

1,456 trials

Showing 20 of 1,456 results

Early research (Phase 1)Ended earlyNCT01086761
What this trial is testing

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

Who this might be right for
Wet Age-Related Macular Degeneration
Allergan 32
Testing effectiveness (Phase 2)WithdrawnNCT02563782
What this trial is testing

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine
Large-scale testing (Phase 3)Study completedNCT04239027
What this trial is testing

Assess the Effects of Brolucizumab in Adult Patients With Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Novartis Pharmaceuticals 210
Very early researchStudy completedNCT04590196
What this trial is testing

Effect of Oral Curcumin Supplementation in Dry Age-related Macular Degeneration (AMD) Patients

Who this might be right for
Age Related Macular Degeneration
University of Illinois at Chicago 10
Early research (Phase 1)Study completedNCT01154062
What this trial is testing

Evaluate Pazopanib Tablets in Patients Who Have Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
GlaxoSmithKline 15
Testing effectiveness (Phase 2)Study completedNCT01342926
What this trial is testing

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 191
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Large-scale testing (Phase 3)Looking for participantsNCT07482176
What this trial is testing

Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD
Adverum Biotechnologies, Inc. 284
Not applicableLooking for participantsNCT06046118
What this trial is testing

Photobiomodulation in Dry Age Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro 180
Not applicableStudy completedNCT01822873
What this trial is testing

Study on Visual Function Impairments in Dry Age-related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Duke University 128
Not applicableStudy completedNCT01694095
What this trial is testing

Evolution and Risk Factors Associated With Geographic Atrophy Progression

Who this might be right for
Geographic Atrophy
Institut de la Macula y la Retina 96
Testing effectiveness (Phase 2)Study completedNCT04331730
What this trial is testing

Assess the Efficacy and Safety of AKST4290 With Aflibercept in Patients With Newly Diagnosed nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Alkahest, Inc. 107
Not applicableStudy completedNCT04776031
What this trial is testing

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

Who this might be right for
Early Age Related Macular Degeneration (Disorder)
Lutronic Vision, Inc 31
Not applicableStudy completedNCT06021366
What this trial is testing

Treatment Patterns With Brolucizumab in Germany - a Retrospective Cohort Study Based on Longitudinal Prescription Data: REALIZE Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 2,089
Not applicableStudy completedNCT00564902
What this trial is testing

The Zeaxanthin and Visual Function Study

Who this might be right for
Age Related Macular DegenerationCognition Disorders
Chrysantis, Inc. 60
Not applicableStudy completedNCT01073592
What this trial is testing

Comparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 10
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Post-approval studies (Phase 4)WithdrawnNCT02634970
What this trial is testing

CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab

Who this might be right for
Wet Age-related Macular Degeneration (Wet AMD)
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT03387566
What this trial is testing

Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Huabo Biopharm Co., Ltd. 21
Not applicableStudy completedNCT00727753
What this trial is testing

VEGF-antagonism and Endothelial Function in Age-related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
University of Zurich 54
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation